Lecture discusses adipose-derived cells' role in generating osteogenic grafts, highlighting their clinical trial application.
This lecture will first introduce the use of human adipose-derived cells to generate pre-vascularized truly osteogenic grafts, with improved engraftment and functionality upon in vivo implantation. The vasculogenic and osteogenic potential of adipose-derived cells will be discussed. Such grafts can be combined to arterio-venous bundles to engineer axially-vascularized osteogenic grafts able to treat and revitalize bone avascular necrosis in a rat model developed in our laboratory. The same principle was recently used as a surgical treatment to achieve improved oral rehabilitation and anatomical and functional reconstruction of a complex defect of the maxilla of a patient with a pedicled engineered composite graft. A pedicled graft was first generated ectopically and later transferred into the bone defect with his vascular pedicle and anastomosed to the vasculature at recipient site. A phase I clinical trial in preparation, following this approach and addressing mandibular reconstruction will also be described.
No takes yet. Share an insight, caveat, or question.
Arnaud Scherberich (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: